Endstage Renal Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-07-22
Clinical Trial Update: The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum [Phase 2]
Phase 2 trial assessing the effect of phosphate lowering with sucroferric oxyhydroxide (PA21) on serum calcification propensity in end-stage…